Post-earnings recap
Reported
Wed, Jan 31, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
Eli Lilly's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 5.39%, likely due to the absence of revenue figures and guidance, which left investors uncertain about future performance. The management's cautious tone may also have contributed to the stock's decline.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.14 | N/A | +3.72% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in the company's future prospects despite the lack of revenue guidance. They emphasized their commitment to innovation and market expansion.
Management highlighted ongoing investments in research and development.
They noted a strong pipeline of products expected to drive future growth.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—